Scientists test magic mushroom drug on older brains to unlock Alzheimer's clues
NCT ID NCT07386730
Summary
This early-stage research study aims to understand how two different drugs—psilocybin (from magic mushrooms) and dextromethorphan (a cough medicine ingredient)—affect brain activity in older adults who report low well-being. Researchers will measure brain waves, inflammation markers, and brain scans in 80 participants aged 50-85 to see if these drugs might influence early Alzheimer's disease indicators. Participants will receive a single dose of one of the drugs during an 8-12 hour monitored session and be followed for up to 3 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANHEDONIA IN HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California San Francisco, Sandler Neuroscience Building
San Francisco, California, 94158, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.